DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Emkay Global Financial Services Limited — Outcome of Board Meeting

NSE 2 hrs ago·27 Jul 2026, 12:08 pm

Emkay Global FIN Serv

Emkay Global Financial Services Limited has informed the stock exchanges that its board has approved the financial results for the period ending June 30, 2026. This announcement confirms that the company has completed the filing of its quarterly financial statements with the relevant authorities.

For investors, this update is a standard procedural step that signals the company's commitment to transparency and regulatory compliance. It provides a formal timeline for the release of detailed financial data, which will be crucial for assessing the firm's current performance and future outlook.

Investors should watch for the detailed financial report to analyze key metrics such as revenue growth, profit margins, and any changes in the company's asset quality. This data will offer deeper insights into the company's operational health and strategic direction.